newsfilter
← Latest News
GlobeNewswire·

Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

Presented preclinical data at the American Society of Clinical Oncology (ASCO) on CLD-401 demonstrating biological efficacy IL-15 superagonist delivery to metastatic tumor sites and reduced immune clearance through